Novel Discoveries and Clinical Advancements for Treating Onychomycosis: A Mechanistic Insight

Area of Science:

• Pharmaceutical Sciences
• Dermatology
• Drug Delivery Systems

Background:

• Onychomycosis presents significant challenges in pharmaceutical drug delivery, leading to incomplete cures and frequent relapses.
• Current management relies on conventional strategies, often insufficient for eradicating the fungal infection effectively.

Purpose of the Study:

• To compile comprehensive information on onychomycosis, including its pathophysiology, diagnostics, and conventional treatments.
• To review novel technologies and patented approaches for enhanced antifungal drug delivery.
• To provide insights into the clinical landscape and future directions for onychomycosis management.

Main Methods:

• Literature compilation and review of existing research on onychomycosis.
• Analysis of diagnostic techniques and conventional treatment modalities.
• Exploration of novel drug delivery systems, including nanocarrier-based vehicles and patented technologies.

Main Results:

• The review synthesizes information on onychomycosis pathophysiology, diagnostics, and current treatments.
• Emerging technologies and patented innovations show potential for improved antifungal delivery.
• Clinical landscape analysis suggests advanced, technology-driven approaches are necessary.

Conclusions:

• Novel technologies, particularly nanocarrier-based delivery systems, are crucial for effective onychomycosis management.
• Advanced approaches are recommended to overcome treatment challenges and reduce relapse rates.
• This review provides a foundation for designing and developing next-generation onychomycosis therapies.